| http://www.w3.org/ns/prov#value | - There are over 75 companies profiled in Kalorama???s recent report on this topic doing some type of molecular POC. Many companies are developing molecular diagnostic platforms and assays that are designed to for near-patient or POC testing, and the earliest of these systems are starting to reach the market.
|
